Dr. Parmis
Lead Medical Researcher
Leads GLP Review's provider scoring and clinical research. Focus areas: GLP-1/GIP receptor agonists, compounded peptides, 503A/503B pharmacy practice, and USP <797> sterile compounding.
GLP Review is published by Ranika Partners LLC. We score GLP-1 telehealth providers against a public rubric — and we don't sell our verdicts.
GLP Review exists to make GLP-1 telehealth scoring legible. The cash-pay compounded-GLP-1 market grew rapidly in 2022–2024 under the FDA Drug Shortages list exception; the post-shortage market that followed is more heterogeneous in quality than its marketing copy suggests. Our published v3.0 six-pillar rubric is our attempt to make the differences that matter — who is prescribing, where the medication is compounded, what the maintenance price actually is — visible enough that a patient can use them.
We are an editorial publication, not a clinical practice. Rankings are non-payable. Affiliate relationships exist; they do not influence scores.
Our research and review work is led by named people with verifiable credentials. Clinical review is advisory and firewalled from scoring. Fact-checking is independent of editorial and is not employed by any reviewed provider.
Lead Medical Researcher
Leads GLP Review's provider scoring and clinical research. Focus areas: GLP-1/GIP receptor agonists, compounded peptides, 503A/503B pharmacy practice, and USP <797> sterile compounding.
Medical Reviewer
Board-certified physician who reviews GLP Review's clinical content for accuracy. Reviews are advisory and do not influence ranking placement.
Editor
Edits GLP Review for clarity, sourcing, and corrections. Maintains the public corrections log and oversees the editorial-independence firewall.
Fact-checker
Independent fact-checker for GLP Review. Verifies primary-source claims for clinical, regulatory, and pricing content; maintains source citation standards. Not employed by any provider in the ranking.
Contributing Clinician
Practicing internist and contributing reviewer on the clinical desk. Reviews drug-page content and condition-specific guidance. Reviews are advisory and do not influence ranking placement; clinical practice is unaffiliated with any reviewed provider.
Rankings are editorial and non-payable. No provider can pay for placement, a higher score, or favorable coverage. GLP Review is affiliate-supported; affiliate relationships never influence scores, which are determined solely by the published v3.0 six-pillar rubric.
GLP Review is affiliate-supported. When a reader selects a provider through a link on our site, the provider may compensate us for the referral. This does not change the scores, the ranking order, the verdict text, or any editorial recommendation. Affiliate arrangements exist with several providers in our directory at varying terms; the highest-paying affiliate is not the top-ranked provider, and ranking changes are not coordinated with affiliate negotiations. We do not run programmatic display advertising.
We do not accept payment for placement, scoring adjustments, or favorable coverage of any kind. This is not a stylistic preference; it is the design of the publication.
Editorial inquiries, corrections, fact-checks, press, and partnership questions all go to [email protected]. See also our press page for citation guidance and the contact page for full inquiry triage.
Publisher: Ranika Partners LLC